EGFR and non-small cell lung carcinoma: Epidermal growth factor receptor (<i>EGFR</i>) exon 19 deletion (Ex19del) is one of the most prevalent sensitizing mutations in non-small cell lung cancer (NSCLC), particularly in Asian populations.